|
CYTSA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80789999970621E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.023500E-04 |
| Normal-vs-Stage2 |
5.441200E-04 |
| Normal-vs-Stage3 |
1.27499999447167E-08 |
| Normal-vs-Stage4 |
8.7406999971229E-08 |
| Stage1-vs-Stage2 |
1.381620E-01 |
| Stage1-vs-Stage3 |
3.171600E-04 |
| Stage1-vs-Stage4 |
1.281690E-03 |
| Stage2-vs-Stage3 |
3.103400E-01 |
| Stage2-vs-Stage4 |
3.445000E-01 |
| Stage3-vs-Stage4 |
9.617000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.2631000001484E-07 |
| Normal-vs-AfricanAmerican |
7.241200E-04 |
| Normal-vs-Asian |
5.969800E-01 |
| Caucasian-vs-AfricanAmerican |
9.029200E-01 |
| Caucasian-vs-Asian |
1.993850E-01 |
| AfricanAmerican-vs-Asian |
2.637400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84189999977258E-07 |
| Normal-vs-Female |
1.80674999999964E-05 |
| Male-vs-Female |
5.052200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.552100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.229380E-04 |
| Normal-vs-Age(61-80Yrs) |
8.21719999821724E-08 |
| Normal-vs-Age(81-100Yrs) |
5.956300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.545250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.551000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.101600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.846200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.019570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.861600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.122600E-01 |
| Normal-vs-Grade 2 |
2.998700E-04 |
| Normal-vs-Grade 3 |
6.38710000444576E-08 |
| Normal-vs-Grade 4 |
8.22560020097285E-10 |
| Grade 1-vs-Grade 2 |
8.213800E-02 |
| Grade 1-vs-Grade 3 |
7.581500E-03 |
| Grade 1-vs-Grade 4 |
1.228280E-04 |
| Grade 2-vs-Grade 3 |
9.883300E-03 |
| Grade 2-vs-Grade 4 |
2.21099999999641E-05 |
| Grade 3-vs-Grade 4 |
1.767720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.955000E-03 |
| Normal-vs-ccB subtype |
3.68189999599977E-08 |
| ccA subtype-vs-ccB subtype |
2.42159999999103E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.45460000003872E-07 |
| Normal-vs-N1 |
1.004170E-03 |
| N0-vs-N1 |
1.853160E-01 |
|
|
